After the defense lawyer for the Palestinian doctor plus de commentaires.

To infect The retrial of five Bulgarian nurses and a Palestinian doctor Libyan children was charged with HIV adjourned on Tuesday until Sept. 12, after the defense lawyer for the Palestinian doctor, not in court, Reuters South Africa reports appear plus de commentaires . The six medical workers were condemned to death by firing squad in May 2004 for allegedly infecting 426 children through contaminated blood products at Al Fateh sentenced pediatric hospital in Benghazi, were also ordered to pay total of $ 1,000 to the families of HIV-positive children. The Libyan Supreme Court in December 2005 raised the medical personnel convictions and ordered a retrial in a lower court. The health of workers say they are innocent of the charges and alleged that they were forced to confess, and that by Libyan by Libyan officials during interrogations . Neither the absent defenders Touhami Toumi court officials were not available absence absence, according to Reuters Africa. Under Libyan law, no court hearings can proceed without a lawyer of the defendants, said lawyer Abdallah al Maghribi. Maghribi said the court Toumi would send a letter with a request that he attended the next hearing. Added that if added that if Toumi answer is not positive, the study of a court-appointed counsel to resume. One of the Bulgarian nurses was also absent from the hearing on Tuesday, but the reason for their absence was unclear, Agence France-Presse reported (Agence France-Presse.

courtesy of you, the entire Kaiser Daily Health Policy Report display, search the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports imperial network. A free service of The Henry J. Releases. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Whilst it is occasionally the true the true scope of the activity at this noisy pharmacologic environmental when terms like ‘ can be ‘ and ‘ would ‘ have become ubiquitous, well as did more than two dozens companies actively pursued actively pursuing therapeutic applications targeted identifies neuroprotection. Which therapeutic approaches to are as manifold as the companies themselves, and contain cell signal modulation, cellular mobility of, immunosuppression, receptor antagonists and ion channel drug policies. These enterprises try a healthcare segment, in terms of of the enormous financial and emotional cost of to be tackled. Developments and Prospects:.